Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial
Conclusions: A single dose of a 10,000μg B12 multivitamin was safe and tolerated. Thus far all patients have achieved and maintained a response for at least six months. This simplified single cobalamin administration is an effective option for the treatment of pernicious anemia.DisclosuresGomez-Almaguer: AbbVie: Consultancy; Novartis: Consultancy.
Source: Blood - Category: Hematology Authors: Pezina Cantu, C. O., Colunga Pedraza, P. R., Gomez De Leon, A., Garcia-Camarillo, D. E., Marquez-Pinedo, O., Santana-Hernandez, P., Cantu Rodriguez, O., Gutierrez Aguirre, C. H., Tarin Arzaga, L. d. C., Gomez-Almaguer, D. Tags: 101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I Source Type: research
More News: Anemia | Brain | Gastroenterology | Hematology | Iron | Laboratory Medicine | Medical Ethics | Neurology | Pernicious Anemia | Statistics | Study | Toxicology | Vitamin B12 | Vitamin B12 Deficiency | Vitamin B6 | Vitamins | Women